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Ste4 is the  subunit of a heterotrimeric G protein that medi-
ates mating responses in Saccharomyces cerevisiae. Here we
show that Ste4 undergoes ubiquitination in response to phero-
mone stimulation. Ubiquitination of Ste4 is dependent on the
E3 ligase Rsp5. Disrupting the activity of Rsp5 abolishes ubiq-
uitination of Ste4 in vivo, and recombinant Rsp5 is capable of
ubiquitinating Ste4 in vitro.We find also that Lys-340 is amajor
ubiquitination site on Ste4, as pheromone-induced ubiquitina-
tion of the protein is prevented when this residue is mutated to
an arginine. Functionally, ubiquitinationdoes not appear to reg-
ulate the stability of Ste4, as blocking ubiquitination has no
apparent effect on either the abundance or the half-life of the
protein. However, when presented with a concentration gradi-
ent of pheromone, Ste4K340R mutant cells polarize significantly
faster than wild-type cells, indicating that ubiquitination limits
pheromone-directedpolarized growth.Together, these findings
reveal a novel stimulus-dependent posttranslational modifica-
tion of a G subunit, establish Ste4 as a new substrate of the E3
ligase Rsp5, and demonstrate a role forG protein ubiquitination
in cell polarization.
G proteins are membrane-associated signal transducers that
transmit signals from cell surface receptors to intracellular
effectors. Without stimulation, G proteins exist as a hetero-
trimer of , , and  subunits. G protein-coupled receptor acti-
vation leads to GDP release, GTP binding, and dissociation of
G-GTP from the G subunits. Depending on the system,
either G or G or both transmit the signal and activate
downstream effectors (1, 2).
Multiplemechanisms exist to ensure thatGprotein signaling
is tightly controlled (2, 3). For instance, the cell surface expres-
sion of receptors is regulated via feedback phosphorylation and
internalization (4). The duration of G protein activation is lim-
ited by regulators of G protein signaling (RGS protein), which
enhance the GTPase activity of G and promote reassociation
of the heterotrimer and G protein deactivation (5). Likewise,
the activity of most effector kinases, such as mitogen-activated
protein kinases, is regulated by the action of phosphatases (6, 7).
The ubiquitin system is now recognized as an important reg-
ulator of cell function (8–10). The process of ubiquitination is
catalyzed by a cascade of enzymes composed of a ubiquitin-
activating enzyme (E1), a ubiquitin-conjugating enzyme (E2),
and a ubiquitin-ligating enzyme or ligase (E3) (8, 9). In most
studied examples, ubiquitin is conjugated to the -amino group
of lysine via the formation of an isopeptide bond (9). Less com-
monly, the free amino terminus of a target protein is used for
conjugation (11). Specificity of ubiquitination is afforded by the
large number of E2 and E3 enzymes, which bind protein sub-
strates with a high degree of selectivity (8, 12). Most substrates
are modified with a polyubiquitin chain, which targets the sub-
strates for degradation by the 26 S proteasome (8). Some pro-
teins, especially those that are membrane-associated, are
mono-ubiquitinated (a single ubiquitin moiety instead of a
polyubiquitin chain is attached to a lysine residue on the sub-
strate) (13). Distinct frompolyubiquitination,monoubiquitina-
tion typically does not lead to proteasome-dependent proteol-
ysis of the protein. Rather, it acts as a signal to regulate
intracellular protein trafficking and/or serves as a mechanism
to modulate protein-protein interactions (14–16). In this
regard, monoubiquitination could function much like phos-
phorylation to affect protein activity.
Evidence is emerging that ubiquitination is involved in the
regulation of G protein signaling (17, 18). In mammalian cells,
several heterotrimeric G protein subunits, including G and
G but not G, are thought to be regulated by the ubiquitina-
tion pathway (17, 18). Among those, direct ubiquitination has
been observed for Gs (19), G2 (20), and transducin G (21).
However, the ubiquitination site in these proteins has not been
identified, and the mechanism and functional consequence of
these ubiquitination events are not fully understood (18).
The G protein pathway is highly conserved across evolution,
allowing the study of fundamental mechanisms of G protein
signaling using simple model organisms such as the Baker’s
yeast Saccharomyces cerevisiae (22). Indeed, many principles of
G protein signaling were initially discovered through studying
the mating pathway in yeast (23). As with other G protein sig-
naling pathways, activation of the yeast mating pathway is ini-
tiated by a ligand (i.e. the mating pheromone) binding to a cell
surface receptor Ste2/Ste3, which in turn promotes GTP bind-
ing to the G subunit Gpa1. GTP triggers dissociation of Gpa1
from the G subunits Ste4/Ste18 (3, 24). Free Ste4/Ste18
transmits the signal, leading to activation of multiple down-
stream effectors including Far1 (a cyclin-dependent kinase
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inhibitor), Cdc24 (exchange factor for a small GTPase Cdc42),
and aMAP kinase cascade comprised of Ste20, Ste11, Ste7, and
Fus3 (3, 23). Activation of Far1 and the MAP kinase cascade
results in growth arrest at G1 and transcription of genes
required for mating (3).
Ste4 also regulates polarized cell growth via interactionswith
Cdc24 andFar1 (3, 25).When cells are treatedwith pheromone,
they reorient their cytoskeleton and initiate polarized growth
toward the highest concentration of pheromone, leading to the
formation of a “shmoo” morphology (26, 27). It is possible that
this behavior allows the yeast to mate with the best partner
available because such yeast cells may release the strongest
mating signal. It has been suggested that Ste4may play a role in
sensing the pheromone gradient, but direct evidence is lacking
(28).
Despite the pivotal roles of Ste4 in activating a multitude of
effectors that are responsible for all aspects of the pheromone
response, Ste4 is not an abundant protein. In fact, earlier work
suggested that Ste4 is the limiting component in the receptor/G
protein complex. Estimates from a large scale quantitative
immunoblotting study indicated that the number of Ste4 mol-
ecules (2050/cell) is much lower than either G Gpa1
(9920/cell) or G Ste18 (5550/cell) (29). Moreover, as little
as 2-fold overexpression of Ste4 (but not Gpa1 and Ste18) is
sufficient to yield full activation of the pathway (30). Given the
limiting abundance of Ste4 and its crucial roles in pheromone
signaling, it is likely that a battery of mechanisms may exist to
regulate its activity to ensure accurate cellular responses to
pheromone treatment.
In this study, we examined the potential role of the ubiquiti-
nation pathway in the regulation of Ste4. We find that Ste4 is
monoubiquitinated and that ubiquitination is stimulated by
pheromone treatment. Through genetic and biochemical anal-
ysis, we identify Rsp5, a homologous to the E6-AP carboxyl
terminus type E3 ligase, as the enzyme responsible for Ste4
ubiquitination. We find also that lysine 340 in Ste4 serves as a
major ubiquitination site. Finally, we find that blocking Ste4
ubiquitination alters the rate of polarized growth triggered by
pheromone stimulation. Together, this study reveals a novel
stimulus-dependent modification of the G protein  subunit
required for proper cell polarization.
EXPERIMENTAL PROCEDURES
Strains and Plasmids—Standard methods for the growth,
maintenance, and transformation of yeast and bacteria and for
the manipulation of DNA were used throughout. The yeast
S. cerevisiae strains used in this study are BY4741 (MATa leu2
met15 his3 ura3), BY4741-derived mutants lacking STE4,
FUS3, or KSS1 (Research Genetics, Huntsville, AL), MYY290
(MATa leu2 his3 ura3), and MYY808 (MATa leu2 his3 ura3
rsp5–1, a temperature-sensitive mutant) (from Dr. Michael
Yaffe, University of California at San Diego) (31), doxycycline-
sensitive yeast strains (MATaURA3::CMV-tTA his3–1 leu2–0
met15–0) (Open Biosystems) (32), YPH499 (MATa ura3–52
lys2–801am ade2–101oc trp1-63 his3-200 leu2-1), and
YPH499-derived mutants lacking STE4 (ste4::KanMX, this
work).
Expression plasmids used in this study that have been
described previously are pYES-His-8-Ubiquitin (33), pYES-
GAL-STE4-FLAG (34), YCp-STE4, and the YCp-STE4-derived
mutants STE4310–346 and STE4T320A/S335A (from Dr. David
Stone, University of Illinois at Chicago) (35). YCp-STE4K340R
was generated by site-directedmutagenesis using YCp-STE4 as
the template. Mutagenesis primers were 5-CAA TCG CCA
CAA ACT TTA AGA TCA ACA AGC TCA AGC TAT CTA
GAC-3 and 5-GTC TAG ATA GCT TGA GCT TGT TGA
TCT TAA AGT TTG TGG CGA TTG-3. pRS306-STE4K340R
was constructed by subcloning the STE4 open reading frame
plus 1000 base pairs of upstream promoter sequence and 472
base pairs of downstream sequence from YCp-STE4K340R into
the EcoRI/NotI sites of pRS306. The PCR primers used were
5-AAG GAA AAA AGC GGC CGC ACA GAA ATA TTT
GAA ATA TAT TTC C-3 and 5-CTA GGA ATT CAA ATT
CAGGCA TTT TTGAAA TTACC-3. The resulting plasmid
was linearized with StuI and integrated at the URA3 locus of
YPH499-derived mutants lacking STE4. The transformants
were selected on SCD-Ura, and the integrations were con-
firmed by immunoblotting of Ste4 protein.
pRS315-His-8-Ubiquitin (CEN/ARS, LEU2,GAL1 promoter,
CYC1 terminator) was constructed by subcloning the GAL1-
His-8-Ubiquitin-CYC1 fragment from pYES-His-8-Ubiquitin
to the SpeI site of pRS315. The PCR primers used were 5-GGA
CTA GTA CGG ATT AGA AG-3 and 5-GGA CTA GTG
CCG ATT CAT TAA TGC AGG GC-3. For construction of
pYES-RSP5-FLAG, a triple-FLAG epitope tag was placed at the
C terminus of Rsp5 (RSP5-FLAG) by PCR amplification and
subcloning into the pYES2.1/V5-His-TOPO (2 m, URA3,
GAL1 promoter, CYC1 terminator) (Invitrogen). PCR primers
were 5-CCCAAGCTTCCAGAATGCCTTCATCCATAT
CCGTC-3, and 5-TTACTTGTCATCGTCATCTTTATA
ATC CTT GTC ATC GTC ATC TTT ATA ATC CTT GTC
ATC GTC ATC TTT ATA ATC CCC AAG CTT TTC TTG
ACC AAA CCC TAT GG-3. The plasmid pDS30 (FUS1-GFP
reporter) was from Daria Siekhaus, University of California,
Berkeley (36).
Signaling and Degradation Bioassays—The pheromone-in-
duced phosphorylation of Fus3 and Kss1 were monitored by
immunoblotting of whole cell extracts with antibodies that spe-
cifically recognize phosphorylated Fus3 and Kss1 (9101, phos-
phor-p44/42 MAPK antibody from Cell Signaling Technology,
Inc.). Specificity of detection was established using fus3 and
kss1 cell extracts as negative controls. The pheromone-de-
pendent transcription assay using the green fluorescent protein
reporter (FUS1-GFP) has been described previously (30, 37). To
monitor the loss of Ste4 over time, early log cell cultures were
treated with 3 M -factor for 60 min, followed by cyclohexi-
mide (10 g/ml in 0.1% ethanol, final concentrations) for up to
2 h. Growth was stopped by the addition of 10 mM NaN3 and
transfer to an ice bath. Cell extracts were prepared via TCA
precipitation, separated by 8% SDS-PAGE, and transferred to a
nitrocellulose membrane (Bio-Rad). The membrane was
probed with antibodies to Ste4 at 1:2000 (from Duane Jenness,
University of Massachusetts), and Pgk1 at 1:75,000 (from Jer-
emy Thorner, University of California, Berkeley, CA). Immu-
noreactive species were visualized by enhanced chemilumines-
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cence detection (Pierce) of horseradish peroxidase-conjugated
anti-rabbit IgG (Bio-Rad) or anti-goat IgG (SantaCruz Biotech-
nology, Inc.). Specificity of detection was established using
ste4 cell extract as a negative control.
Isolation of Ste4 Conjugated to His-tagged Ubiquitin—Ubiq-
uitination of Ste4 was detected by purifying His-tagged ubiqui-
tin conjugates as described previously (33), followed by immu-
noblottingwith antibodies thatwere raised against Ste4. Briefly,
wild-type or ste4 mutant cells were transformed with either
pYES-His-8-Ubiquitin or vector and were grown in synthetic
galactose medium to early log phase. Upon treatment with
pheromone (3 M) for the indicated time, about 60 A600 cells
from each culture were harvested by centrifugation. Extracts
were prepared for metal affinity purification of His-tagged
ubiquitin and conjugates by methods that were adapted from
Muratani et al. (38). Each cell pellet was suspended in 650 l of
buffer A2 (6 M guanidine-HCl, 100 mM Na2HPO4/NaH2PO4
(pH 8.0), 10 mM imidazole, 250 mMNaCl, 0.5%Nonidet P-40, 2
mM N-ethylmaleimide, and 1 pellet of complete EDTA-free
protease inhibitor (Roche) for every 50 ml of buffer). Suspen-
sionswere subjected to eight cycles of glass bead vortex homog-
enization of 30 s each. The lysates were solubilized bymixing at
4 °C for 1 h and clarified by two rounds of centrifugation at a
speed of 12,000  g for 5 min and 25 min at 4 °C. The resulting
supernatants were incubated with TALON Superflow metal
affinity resin (BD Biosciences, Clontech) for 2 h at room tem-
perature with rocking. Following this incubation, the resin was
washed twice with buffer A2, twice with buffer A2/T2 (1 vol-
ume of buffer A2 and 3 volumes of buffer T2 (50mMNa2HPO4/
NaH2PO4 (pH 8.0), 250mMNaCl, 20 mM imidazole, 0.5%Non-
idet P-40), and twice with buffer T2. Resin was then washed
with buffer T2 containing 50 mM histidine to reduce the reten-
tion of proteins that nonspecifically bind to the resin. Finally,
8His-ubiquitin and any conjugated proteins were eluted with
2 SDS-PAGE loading buffer. Samples of the metal affinity-
purified proteins and total extract were resolved by 7.5% SDS-
PAGE and transferred to nitrocellulose. Detection of Ste4 was
carried out with anti-Ste4 antibodies followed by goat anti-rab-
bit IgG-HRP (Santa Cruz Biotechnology, Inc.) at 1:6000. Visu-
alization of HRP-conjugated complexes was accomplished by
the enhanced chemiluminescence Reagent Plus from Perkin-
Elmer Life Sciences.
Immunoprecipitation—The association of Ste4 and Rsp5was
examined by immunoprecipitation of FLAG-tagged Rsp5 and
immunoblotting with anti-Ste4 antibodies. Cells transformed
with pYES-RSP5-FLAG or empty vector were grown to early
log phase, treated as indicated with 3 M pheromone for 60
min, harvested by centrifugation, and resuspended in 550 l of
lysis (FLAG/Triton) buffer (50 mM NaPO4 (pH 7.5), 400 mM
NaCl, 0.1% Triton X-100, 10% glycerol, 0.5 mM dithiothreitol,
25mMNaF, 25mMglycerophosphate, 1mM sodiumorthovana-
date, 10 mM N-ethylmaleimide, 5 mM phenylmethylsulfonyl
fluoride, and one pellet of complete EDTA-free protease inhib-
itor mixture (Roche) for every 50 ml of buffer). This and all
subsequent manipulations were carried out at 4 °C. Cells were
subjected to glass bead vortex homogenization for 30 s,
repeated eight times, and centrifuged twice at 6000  g for 5
min and 25 min. Lysates were incubated for 2 h with a bead
volume of 10 l of anti-FLAGM2 affinity resin (Sigma) equili-
brated in lysis buffer. Immunoprecipitates were collected by
centrifugation at 1000 g for 30 s, andpelletswerewashedwith
1ml of lysis buffer for 3min and repeated four times before final
resuspension in 30 l of 2 SDS-PAGE loading buffer. Each
sample was resolved by 7.5% SDS-PAGE and immunoblotting
with anti-Ste4 antibodies at 1:1000 or anti-FLAG monoclonal
antibodies at 1:2000.
Purification of Ste4—FLAG-tagged Ste4 was purified from
the ste4 cells transformed with plasmid pYES-GAL-STE4-
FLAG. Expression of Ste4 was induced by switching early log
phase cells to galactose-containing media for 8 h. Briefly, cells
were grown in glucose-containing medium to A600 0.8, har-
vested by centrifugation, resuspended in galactose-containing
medium to A600 0.3, and grown for an additional 8 h to induce
the expression of Ste4-FLAG. After treatment with 3 M pher-
omone for 60 min, cells were harvested by centrifugation and
resuspended in lysis (FLAG/Triton) buffer. Ste4-FLAG was
immunoprecipitated using anti-FLAGM2 resin. The immuno-
precipitates were collected by centrifugation at 1000  g for
30 s, and the pellet was washed four times with lysis buffer (10
ml for the first wash and 1 ml for the remaining three washes),
four times with 1 ml of 1 ubiquitination buffer (25 mM Tris
(pH 7.5), 50mMNaCl, 4mMMgCl2), andwas stored in glycerol-
containing 1 ubiquitination buffer (25 mM Tris (pH 7.5), 50
mM NaCl, 4 mM MgCl2, 30% glycerol) prior to the ubiquitina-
tion reaction.
In Vitro Ubiquitination of Ste4 by Rsp5—In vitro ubiquitina-
tion reactions were conducted in compact reaction columns
(USB Corp.) with Ste4-FLAG immobilized on M2 FLAG affin-
ity beads. (Note: We observed that elution with FLAG/Triton
buffer prior to the ubiquitination reaction inhibited Rsp5 cata-
lytic activity). Briefly, 15 l of bead-immobilized Ste4-FLAG
representing 15% of a single affinity purification from a 3,600A
cell pellet was prewashed with 0.7 ml 1 ubiquitin assay buffer
(25 mMTris (pH 7.5), 50 mMNaCl, 4 mMMgCl2) to remove the
glycerol storage buffer. Ubiquitination assay components were
then added to the beads, including (unless otherwise indicated)
1 M human E1-activating enzyme Uba1 (Boston Biochem), 1
M yeast E2-conjugating enzyme Ubc5b, 0.2 M yeast E3 ligase
Rsp5 (or the catalytically inactive mutant Rsp5C777A), 5 M
ubiquitin, and 4.8mMATP (Sigma-Aldrich), resulting in a 25l
final reaction volume (beads plus liquid). Reactions were
allowed to proceed for 30 min at room temperature and then
quenched by addition of SDS (to 2% final) and heated to 95 °C
for 2 min followed by dilution with 6 SDS-PAGE loading
buffer containing 100 mM DTT. Ubiquitination of Ste4-FLAG
was detected by 10% SDS-PAGE and immunoblotting with
anti-FLAG antibody as described above.
PolarizedGrowth—Cellswere grown toA600 0.2, treatedwith
dimethyl sulfoxide (1%, final concentration) for 1.5 h before the
addition of nocodazole (15 g/ml in 1% dimethyl sulfoxide,
final concentrations) for 2.5–3 h. Cultures were visualized by
microscopy to confirmG2/M arrest. The cells were then loaded
into amicrofluidics device as described previously (39), and the
nocodazolewaswashed out for 20min prior to stimulationwith
150 nM  factor. Note that the concentration of  factor
required to give a good response in liquid culture is much
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higher because of accumulation of Bar1 and degradation of the
 factor. Cells were imaged at 2-min intervals for 2 h. For each
cell, the time at which the first sign of polarized growth detect-
able in the differential interference contrast image was
recorded and plotted as a function of time.
RESULTS
Ste4 is the subunit of a heterotrimeric G protein thatmedi-
ates mating responses in S. cerevisiae. Earlier studies indicate
that Ste4 represents a crucial component in the pathway, and its
activity must be tightly regulated (30, 40). Growing evidence
suggests that ubiquitination is involved in the regulation of G
protein signaling (17, 18). Thus, we considered the possibility
that Ste4 may be regulated via ubiquitination.
Pheromone Stimulation Induces Ubiquitination of Ste4—To
examine whether Ste4 undergoes ubiquitination, we exploited
an affinity purification method for isolating ubiquitin-conju-
gated proteins (38). Cells were transformed with a plasmid that
expresses poly-His-tagged ubiquitin (His-8-Ubi)2 from the
GAL1 promoter or an empty vector as a control. Cells were
treated with mating pheromone  factor over time and col-
lected at the indicated time points. Extracts from collected
cell pellets were prepared for affinity purification. The puri-
fications were conducted under denaturing conditions to
dissociate Ste4 from other ubiquitinated proteins that hap-
pen to bind Ste4 via non-covalent interactions. Samples of the
extracts and purified proteins were resolved by SDS-PAGE and
analyzed by immunoblotting.
Immunoblot analysis of whole-cell lysates specifically identi-
fied Ste4, as this species is clearly absent in the ste4 mutant
(Fig. 1, top panel). The pheromone-induced mobility-shift of
Ste4 is because of phosphorylation, as documented previously
(35, 41). The population of His-8-Ubi-conjugated proteins spe-
cifically isolated by affinity purification is shown on the anti-
ubiquitin blot (Fig. 1, bottom panel). Immunoblotting of the
affinity-purified His-8-Ubi-conjugated proteins with anti-Ste4
antibodies revealed a discrete band of about 70 kDa (Fig. 1,
center panel). The intensity of the 70-kDa band was signifi-
cantly increased in the pheromone-treated samples, peaking 60
min after pheromone addition. The 70-kDa band as well as the
minor species around itwere completely absent from the vector
and ste4 control samples (Fig. 1, center panel), indicating that
they represent ubiquitinated Ste4. Because the majority of
ubiquitinated Ste4 exists as a discrete band rather than a ladder
of high molecular weight bands, it is very likely that Ste4 is
modified with a single ubiquitin moiety. Taken together, this
analysis shows that Ste4 is monoubiquitinated and that ubiq-
uitination of Ste4 is promoted by pheromone treatment.
Ubiquitination of Ste4 May Be Regulated via Its Prior
Phosphorylation—Next, we investigated potential mechanisms
that may regulate Ste4 ubiquitination. Phosphorylation is a
common mechanism that targets signaling proteins for ubiq-
uitination (9, 42). Ste4 is rapidly phosphorylated following
pheromone stimulation (Fig. 1, top panel) (35, 41), raising the
possibility that there may be a mechanistic link between these
twomodifications. The precise phosphorylation sites of Ste4, as
well as the kinase responsible, have not been definitively iden-
tified (3). Thus, we are not able to directly test whether phos-
phorylation is required for Ste4 ubiquitination. However, pre-
vious work did map Ste4 phosphorylation to a small region
encompassing residues 310 to 346. Phosphorylation is com-
pletely blocked in a mutant form of Ste4 that lacks this region
(Ste4310–346) (41). A mutagenesis analysis of serine and thre-
onine residues within this region suggested that phosphoryla-
tion of Ste4 occurs on residues Thr-320 and Ser-335, as phos-
phorylation is significantly impaired in the Ste4T320A/S335A
mutant (35). To test whether these residues are required for
Ste4 ubiquitination, we examined the ubiquitination status
of the Ste4T320A/S335A mutant. As shown in Fig. 2, the
Ste4T320A/S335A mutant displays a substantial decrease in the
level of ubiquitination. The remaining residual ubiquitina-
tion might be due to residual phosphorylation of the mutant
(Fig. 2). These data suggest that phosphorylation is required
for Ste4 ubiquitination.2 The abbreviation used is: His-8-Ubi, His-8-tagged ubiquitin.
FIGURE 1. Ste4 undergoes ubiquitination in response to pheromone
stimulation. Wild-type or ste4 cells were transformed with either empty
vector or a plasmid expressing His-8-tagged ubiquitin (His8-Ubi). Early log
phase cells were treated with 3 M pheromone for the indicated time (min).
His-8-Ubi-conjugated proteins were purified from whole cell lysates under
denaturing conditions. The level of Ste4 in the whole cell extracts (WCE) prior
to purification was detected by immunoblotting (IB) with anti-Ste4 antibod-
ies (top panel). The purified samples were analyzed by immunoblotting with
anti-Ste4 antibodies (center panel) and anti-ubiquitin antibodies (bottom
panel). p-Ste4, phosphorylated Ste4; Ubi-Ste4, ubiquitinated Ste4.
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Ubiquitination of Ste4 Is Dependent on the E3 Ligase Rsp5—
Monoubiquitination of many plasma membrane-associated
proteins, including Ste2 and Gpa1, is catalyzed by Rsp5, a
HECT-type E3 ubiquitin ligase (43, 44). One unique feature of
Rsp5 is that it can form strong interactions with its substrates
(45). Thus, to test whether Rsp5 may be the ligase responsible
for Ste4 ubiquitination, we first examined whether there is any
detectable interaction between Ste4 andRsp5. For this purpose,
FLAG-tagged Rsp5 was expressed in either wild-type or the
ste4 mutant and was purified via immunoprecipitation from
cultures treated or not treated with mating pheromone. Copu-
rification of Ste4 with Rsp5 was examined via immunoblotting
of the purified samples with anti-Ste4 antibodies. As shown in
Fig. 3A, Ste4 indeed copurifies with Rsp5.
Having detected interactions between Rsp5 and Ste4, we
asked whether Rsp5 is required for in vivo ubiquitination of
Ste4. RSP5 is an essential gene. To determine the consequences
of Rsp5 depletion, we used a strain inwhich the promoter of the
RSP5 gene has been replacedwith a tetracyclin-regulatable pro-
moter (32). In this strain, addition of doxycycline will turn off
transcription of the RSP5 gene. As shown in Fig. 3B, ubiquiti-
nation of Ste4 is completely blocked after turning off the
expression of the RSP5 gene. Ubiquitination of Ste4 is also
blocked in amutant strain that harbors a temperature-sensitive
allele of RSP5 (rsp5–1), grown at the restrictive temperature
(31) (supplemental Fig. 1). These data indicate that Rsp5 is
required for the ubiquitination of Ste4 in vivo.
The above analysis clearly shows that Rsp5 is necessary for
ubiquitination of Ste4. To determine whether Rsp5 is suffi-
cient for Ste4 ubiquitination, we conducted an in vitro
ubiquitination assay using purified recombinant Rsp5 in the
presence of E1 ubiquitin-activating enzyme, E2 ubiquitin-con-
jugating enzyme, ubiquitin, andATP.As shown in Fig. 4, recon-
stitution of the ubiquitinating enzymes with purified Ste4
resulted in the formation of monoubiquitinated Ste4. Impor-
FIGURE 2. Phosphorylation may be required for Ste4 ubiquitination. Cells
expressing either wild-type Ste4 or Ste4T322A/S335A were transformed with
either an empty vector or a plasmid expressing His-8-tagged ubiquitin (His8-
Ubi). Early log phase cells were treated with 3 M pheromone for 60 min.
His-8-Ubi-conjugated proteins were purified from whole cell lysates under
denaturing conditions. The level of Ste4 in the whole cell extracts (WCE) prior
to purification was detected by immunoblotting (IB) with anti-Ste4 antibod-
ies (top panel). The purified samples were analyzed by immunoblotting with
anti-Ste4 antibodies (center panel) and anti-ubiquitin antibodies (bottom
panel). p-Ste4, phosphorylated Ste4; Ubi-Ste4, ubiquitinated Ste4.
FIGURE 3. Rsp5 is required for Ste4 ubiquitination in vivo. A, Ste4 coimmu-
noprecipitates with Rsp5. Wild-type or ste4 cells were transformed with
either an empty vector or a plasmid expressing FLAG-tagged Rsp5 (Rsp5-
FLAG). Early log phase cells were treated with 3 M pheromone for 1 h. FLAG-
tagged Rsp5 was immunoprecipitated (IP) using anti-FLAG M2 resin, and the
copurified Ste4 was detected by immunoblotting of the immunoprecipitates
(IP: Flag) using anti-Ste4 antibodies. The relative level of input Ste4 and Rsp5-
FLAG in the whole cell extracts (WCE) prior to purification is shown in the
lower panels. B, turning off RSP5 expression abolishes Ste4 ubiquitination.
Wild-type (TetO7-WT) or TetO7-RSP5 (RSP5 under the control of doxcyclin-
regulatable promoter) cells were transformed with either an empty vector or
a plasmid expressing His-8-tagged ubiquitin (His8-Ubi). Early log phase cells
were treated or not treated with 60 g/ml doxycycline (Dox) for the indicated
time (h), followed by treatment of 3 M pheromone for 1 h. His-8-Ubi-conju-
gated proteins were purified from whole cell lysates under denaturing con-
ditions. The level of Ste4 in the whole cell extracts (WCE) prior to purification
was detected by immunoblotting (IB) with anti-Ste4 antibodies (top panel).
The purified samples were analyzed by immunoblotting with anti-Ste4 anti-
bodies (center panel) and anti-ubiquitin antibodies (bottom panel). p-Ste4,
phosphorylated Ste4; Ubi-Ste4, ubiquitinated Ste4.
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tantly, exclusion of E1 (Uba1) or incubation with a catalytically
inactive form of Rsp5 (Rsp5C777A) does not result in the pro-
duction of monoubiquitinated Ste4 (Fig. 4). These data show
that Rsp5 is sufficient to ubiquitinate Ste4.
Lys340 Is Required for Pheromone-induced Ubiquitination of
Ste4—Next, we sought to identify the site of Ste4 ubiquitina-
tion. For this purpose, we made use of a recently developed
bioinformatics tool (UbPred) that identifies lysine residues
likely to serve as an ubiquitination site (46). Analyzing the Ste4
sequence with this tool revealed lysine 340 as the highest prob-
ability ubiquitination site among all 22 lysine residues in the
protein. To test whether Lys-340 indeed serves as an ubiquiti-
nation site, we mutated it to an arginine residue, expressed the
mutant from an integrated gene, and examined its ubiquitina-
tion status. Although basal ubiquitination is still detectable in
the Ste4K340R mutant, pheromone-induced ubiquitination is
nearly completely abolished (Fig. 5). Therefore, our data indi-
cate that Lys-340 is primarily responsible for pheromone-in-
duced ubiquitination of Ste4.
Functional Consequences of Ste4 Ubiquitination—Having
identified the site of ubiquitination and the enzyme responsi-
ble, we next sought to determine the functional consequences
of ubiquitination. Because ubiquitination typically leads to pro-
tein degradation, we first investigated whether ubiquitination
regulates the stability of Ste4. For this purpose, we added the
protein synthesis inhibitor cycloheximide to pheromone-
treated cells either expressing wild-type Ste4 or the ubiquitina-
tion site mutant and monitored the protein levels for up to 2 h.
As shown in Fig. 6A, there is no obvious difference between the
stability of the wild type and that of Ste4K340R. Similarly, block-
ing ubiquitination of Ste4 by switching off the expression of
RSP5 did not appear to alter the stability of Ste4 (Fig. 6B). On
the basis of these data, we conclude that ubiquitination does not
alter the stability of Ste4 protein.
Ubiquitination, and in particularmonoubiquitination, can in
some cases alter protein function. Thus, we next investigated
FIGURE 4. Rsp5 ubiquitinates Ste4 in vitro. Bead-immobilized Ste4-FLAG
was incubated with Rsp5 or catalytically inactive Rsp5 (Rsp5-C/A) in the
absence or presence of E1 activating enzyme (Uba1). All reactions contained
Ubc5b, ATP, and ubiquitin. Reactions were stopped after 30 min with 2% SDS.
Proteins were separated by 10% SDS-PAGE, transferred to nitrocellulose
membranes, and blotted with M2 anti-FLAG antibody and goat-anti-mouse-
HRP secondary antibody. Monoubiquitination slows the electrophoretic
mobility of Ste4-FLAG by the approximate mass of ubiquitin (8 kDa). Long
(top panel) and short exposures (center panel) are shown. After immunoblot-
ting, the nitrocellulose blot was stained with Coomassie to show Rsp5 autou-
biquitination and Uba1 loading (bottom panel). *, antibody heavy chain.
Because we observed that FLAG peptide elution buffer inhibited Rsp5 cata-
lytic activity, we conducted in vitro ubiquitination with bead-immobilized
Ste4-FLAG, which may also reduce reaction efficiency.
FIGURE 5. Lys-340 is required for pheromone-induced ubiquitination of
Ste4. Cells expressing either wild-type Ste4 or Ste4K340R were transformed
with either an empty vector or plasmids expressing His-8-tagged ubiquitin
(His8-Ubi). Early log phase cells were treated with 3 M pheromone for 60 min.
His-8-Ubi-conjugated proteins were purified from whole cell lysates under
denaturing conditions. The level of Ste4 in the whole cell extracts (WCE) prior
to purification was detected by immunoblotting (IB) with anti-Ste4 antibod-
ies (top panel). The purified samples were analyzed by immunoblotting with
anti-Ste4 antibodies (center panel) and anti-ubiquitin antibodies (bottom
panel). p-Ste4, phosphorylated Ste4; Ubi-Ste4, ubiquitinated Ste4.
FIGURE 6. Blocking ubiquitination does not alter the stability of Ste4.
A, cells expressing either wild-type Ste4 or Ste4K340R were grown to early log
phase, treated with 3 M pheromone for 1 h, and followed by treatment with
the protein synthesis inhibitor cycloheximide for the indicated times. The
level of Ste4 and Ste4K340R was detected by immunoblotting (IB). B, early log
TetO7-RSP5 (RSP5 under the control of doxycycline-regulatable promoter)
cells were first not-treated (-Dox) or treated with doxycycline (Dox) for 9 h
(to switch off RSP5 expression in the TetO7-RSP5 cells). Cells were then treated
with 3 M pheromone for 1 h, followed by treatment with the protein synthe-
sis inhibitor cycloheximide for the indicated times. The abundance of Ste4
was detected by immunoblotting (IB). Equal loading of each lane was con-
firmed by immunoblotting with anti-Pgk1. Note that Ste4 is dephosphory-
lated more prominently in the TetO7-RSP5 strain, which resulted in the
appearance of two bands.
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whether ubiquitination of Ste4 affects its ability to transmit the
pheromone signal. Upon stimulation, Ste4 activates several
effectors leading to highly coordinated mating responses,
including growth arrest, new gene transcription, and morpho-
logical changes (3, 27). Ste4 activates a MAP kinase cascade by
recruiting the MAP kinase scaffold (Ste5) and the associated
kinase complex (Ste11/Ste7/Fus3) to the plasma membrane
and facilitating its activation by Ste20 (3, 47). To determine
whether ubiquitination of Ste4 plays any role in regulating the
magnitude and/or duration of MAPK activation, we compared
the activation status of Fus3 in wild-type cells versus the
Ste4K340R mutant treated with the mating pheromone  factor
over time. Fus3 activity was monitored by immunoblotting
with an antibody directed against the dually phosphorylated
form of the protein (Thr-202/Tyr-204) (p44/42) (48, 49). As
shown in Fig. 7A, no obvious difference in either themagnitude
or duration of Fus3 activation was detected between wild-type
and the Ste4K340R mutant. Consistent with this result, the
Ste4K340R mutant displayed the same level of pheromone-in-
duced activation of gene transcription as measured by the
FUS1-GFP reporter (50, 51) (Fig. 7B). This analysis indicates
that Ste4 ubiquitination plays no apparent role in regulating the
MAP kinase cascade.
In addition to activating a MAP kinase cascade via binding
Ste5 and Ste20, Ste4 also regulates polarized cell growth via
interactionswithCdc24 and Far1 (3, 25).When cells are treated
with pheromone, they reorient their cytoskeleton and initiate
polarized growth toward the highest concentration of phero-
mone, leading to the formation of a shmoo morphology (26,
27). To determine whether ubiquitination of Ste4 may regulate
this process, we compared the polarized cell growth of the wild
type and the Ste4K340R mutant via live cell microscopy. To
ensure consistent Ste4 expression from cell to cell, the
Ste4K340R mutant was integrated to the genome. To minimize
the potential effects of the cell cycle, the cells were synchro-
nized to M phase via nocodazole treatment before pheromone
stimulation. To maintain a consistent environment with con-
stant replenishment of media and pheromone, washout of
nocodozole and treatment with pheromone was done in a
microfluidic chamber (39). As shown in Fig. 8, cells start to
undergo polarized growth after 30 min of pheromone treat-
ment. By 80 min of treatment, the majority of cells display
polarized growth. However, the kinetics of polarized growth
displayed by the wild type and Ste4K340Rmutant are very differ-
ent. On average, the population of Ste4K340R mutants polarizes
significantly faster than thewild type (Fig. 8). Such a behavior of
the Ste4K340R mutant indicates that ubiquitination regulates
the process of pheromone-triggered polarized growth.
DISCUSSION
Heterotrimeric G proteins are molecular switches that con-
trol many important biological processes. Thus, a clear under-
standing of themechanisms that regulateGproteins is essential
for revealing new disease mechanisms and for designing novel
approaches for pharmaceutical intervention. In this report, we
showed that the G protein undergoes ubiquitination in
response to pheromone stimulation. To our knowledge, this is
the first demonstration of stimulus-dependent ubiquitination
of a G protein subunit in any system.
FIGURE 7. Ubiquitination of Ste4 does not regulate the magnitude and
duration of pheromone-induced activation of MAP kinases. A, whole cell
extracts were prepared from the wild type and the Ste4K340R mutant treated
with 3 M pheromone  factor for the indicated time, resolved by 10% SDS-
PAGE, and probed with anti-phospho-p44/42 (top panel) or anti-Ste4 (bottom
panel) antibodies. p-Mpk1, p-Kss1, and p-Fus3 denote phosphorylated and
thus activated Mpk1, Kss1, and Fus3. B, pheromone-dependent transcrip-
tional induction was measured following transformation of the above cells
with a pheromone-responsive FUS1 promoter-GFP reporter. Cells were then
treated with 3 M -factor for 90 min, and the resulting fluorescence in each
cell was monitored by cell sorting. Pathway activation results in an increase in
cells with 40 fluorescence units of activity (as indicated by an M1 bar on
each graph).
FIGURE 8. Ubiquitination of Ste4 limits pheromone-induced polarized
growth. Cells expressing either wild-type Ste4 or Ste4K340R were grown to
A600 0.2 and treated with dimethyl sulfoxide (1%, final concentration) for 1.5 h
before the addition of nocodazole (15 g/ml in 1% dimethyl sulfoxide, final
concentrations) for 2.5–3 h. Cultures were visualized by microscopy to con-
firm G2/M arrest. The cells were then loaded into a microfluidics device, and
the nocodazole was washed out for 20 min prior to stimulation with 150 nM 
factor. Cells were imaged at 5 min intervals for 2 h. For each cell, the time at
which the first sign of polarized growth detectable in the differential interfer-
ence contrast image was recorded and plotted as a function of time. The
slope was taken from the linear portion of each curve, and the average slopes
from three independent experiments are shown in the bar graph (right panel).
The difference between Ste4 and Ste4K340R was statistically analyzed by t test.
*, p  0.05). Error bars, mean  S.E.
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Our findings show that Rsp5 is responsible for Ste4 ubiquiti-
nation. First, either turning off Rsp5 expression (the TET-RSP5
strain in the presence of doxycycline) or disrupting Rsp5 func-
tion (the temperature-sensitive rsp5–1 mutant) completely
abolishes Ste4 ubiquitination in vivo. Second, Ste4 physically
interacts with Rsp5 in yeast. Third, Rsp5 is capable of ubiquiti-
nating Ste4 in vitro. Notably, earlier studies showed that Rsp5 is
also responsible for the ubiquitination of Ste2 (receptor) (44)
and themonoubiquitination (but not the polyubiquitination) of
Gpa1 (G) (43). Thus, Ste4 joins a growing list of signaling
proteins that serve as substrates of Rsp5. It would be interesting
to examine whether there is any coordination among these
ubiquitination events. Given the easily detectable interaction
between Rsp5 and Ste4, an attractive model is that Ste4 may
serve as an adaptor protein (in addition to being a substrate) for
Rsp5 to facilitate its ubiquitination of other membrane-associ-
ated proteins. However, monoubiquitination of Gpa1 is appar-
ently not dependent on Rsp5/Ste4 interaction because similar
level of mono-ubiquitinated Gpa1 is present in the wild type
versus a ste4 mutant3.
Although polyubiquitination is commonly regarded as a
degradation signal, monoubiquitination appears to have a
distinct role in protein regulation (13, 52). In accord with
this view, monoubiquitination does not appear to modulate
Ste4 stability. Blocking ubiquitination of Ste4, either via
mutating its major ubiquitination site (Lys-340) or turning
off the expression of its ligase Rsp5, has no obvious effect on
either the abundance or the stability of Ste4. In addition, the
abundance of Ste4 is not discernibly decreased in response to
pheromone treatment, a condition that markedly induces
Ste4 ubiquitination (Fig. 1). This is in marked contrast with
both Ste2 and Gpa1. In both cases, ubiquitination by Rsp5
serves to target the proteins for internalization and eventual
degradation in the vacuole (43, 44).
Thus, although Ste4 is a critical determinant of the intensity
and duration of downstream MAP kinase signaling (30, 40),
ubiquitination does not appear to alter the abundance of Ste4
and thereby the intensity of downstreamMAP kinase signaling.
Rather, ubiquitination of Ste4 appears to have a very specific
role in regulating the timing of polarized cell growth in
response to pheromone stimulation. Compared with the wild
type, the point mutation (Ste4K340R) that blocks ubiquitination
allows cells to polarize significantly faster. On average, the
mutant cells initiate polarized growth 8–10min earlier than the
wild type upon stimulation by pheromone. Further investiga-
tion will be needed to determine how ubiquitination of Ste4
selectively regulates one effector (cell polarity machinery) but
not the other (i.e. a MAP kinase cascade).
Growing evidence indicates that ubiquitination, especially
monoubiquitination, can modulate protein-protein interac-
tions, which consequently can lead to a very specific outcome
(14). A prominent example is K-Ras, a small GTPase that con-
trols cell differentiation and growth. It has been shown that a
very small fraction of K-Ras is modified by mono- or diubiqui-
tin (53). Interestingly, ubiquitinated K-Ras has substantially
increased affinity toward some but not all of its downstream
effectors (53). Consequently, blocking ubiquitination of K-Ras
impacts some but not all of the cellular responses controlled by
the protein. In the case of Ste4, it is entirely possible that ubiq-
uitination may serve to regulate its interaction with down-
stream effectors such as Far1, Cdc24, Ste5, and Ste20. However,
it should be pointed out that the difference of binding could be
subtle, dynamic, and limited to certain subcellular locations.
Therefore, typical coimmunoprecipitation may fail to capture
those potential differences.
How is ubiquitination of Ste4 itself regulated? Pheromone
stimulation induces both phosphorylation and ubiquitination
of Ste4. In agreementwith amodel that phosphorylation targets
Ste4 for ubiquitination, a mutant (Ste4T320A/S335A) that signif-
icantly diminishes phosphorylation of Ste4 also substantially
abolishes ubiquitination. It is interesting to note that the major
ubiquitination site Lys-340 is adjacent to the putative phos-
phorylation sites (Thr-320 and Ser-335), raising a possibility
that phosphorylationmay lead to a conformational change that
helps to expose the lysine residue to receive an activated ubiq-
uitin from Rsp5. However, in consideration of this model, it is
important to keep in mind that Thr-320 and Ser-335 were
implicated as possible phosphorylation sites on the basis of
their requirement for the phosphorylation-induced mobility
shift (35). Thus, it remains possible that the Ste4T320A/S335A
mutant may reduce phosphorylation through an indirect
mechanism.
In summary, our data clearly demonstrate that the G sub-
unit Ste4 undergoes pheromone-dependent ubiquitination and
that Rsp5 is responsible for thismodification. Ubiquitination of
Ste4 occurs primarily on a single lysine residue. Significantly,
ubiquitination of Ste4 selectively regulates some (e.g. polarized
cell growth) but not other aspects of pheromone responses.
Together, these findings reveal a newmechanism for regulating
signal transmission mediated by G proteins.
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